Home › Cancro metastatico › Alabama › Birmingham
Studi clinici su Cancro metastatico a Birmingham, AL
10 studi su Cancro metastatico cercano partecipanti presso sedi a Birmingham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
PRE-ISPY Phase I/II Oncology Platform Program
In reclutamentoFase 1/2
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
In reclutamentoFase 2/3
- The University of Alabama at Birmingham, Birmingham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
In reclutamentoFase 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- University of Alabama at Birmingham, Birmingham
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Clinical Study Site, Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
In reclutamentoFase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Alabama at Birmingham, Birmingham
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
In reclutamentoFase 3
- Central Alabama Research, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Birmingham
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Birmingham
- Cancro (tutti i tipi)30 studi
- Cancro al seno24 studi
- Obesità23 studi
- Cancro ovarico23 studi
- Cancro del polmone non a piccole cellule22 studi
- Leucemia mieloide acuta21 studi
- Mieloma multiplo18 studi
- BPCO17 studi
- Malattie cardiovascolari17 studi
- Sovrappeso16 studi
- Cancro dell'endometrio16 studi
- Diabete di tipo 216 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.